Neratinib in HER2-Positive Breast Cancer Patients

about

Neratinib in HER2-Positive Breast Cancer Patients

Item

http://www.wikidata.org/entity/Q90875656

description

scientific article published on 04 January 2019

@en

name

Neratinib in HER2-Positive Breast Cancer Patients

@en

type

Item

label

Neratinib in HER2-Positive Breast Cancer Patients

@en

prefLabel

Neratinib in HER2-Positive Breast Cancer Patients

@en

P1476

Neratinib in HER2-Positive Breast Cancer Patients

@en

P2093

Dima Basatneh

http://www.w3.org/2001/XMLSchema#string

Gabriel Tao

http://www.w3.org/2001/XMLSchema#string

Romi Ghose

http://www.w3.org/2001/XMLSchema#string

Rutugandha Paranjpe

http://www.w3.org/2001/XMLSchema#string

Sobia Noormohammed

http://www.w3.org/2001/XMLSchema#string

Susan Abughosh

http://www.w3.org/2001/XMLSchema#string

P304

612-620

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1060028018824088

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Meghana V Trivedi

Carmine De Angelis

Ekim Ekinci

P577

2019-01-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30607980

http://www.w3.org/2001/XMLSchema#string

Neratinib in HER2-Positive Breast Cancer Patients

about

Neratinib in HER2-Positive Breast Cancer Patients

description

name

type

label

prefLabel

P1433

P1476

P2093

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P304

P31

P356

P433

P478

P50

P577

P698